European markets are experiencing a downturn, with Asian chipmakers also facing significant losses amid a global stock sell-off. Concerns are rising about a potential equity correction, as highlighted by Deutsche Bank. Meanwhile, China has ended tariffs on US imports, including farm goods, although soybean levies remain in place. The Financial Conduct Authority has extended its consultation on an £11 billion compensation scheme related to a loan scandal, pushing the deadline past the UK's crucial autumn budget. This situation is important as it reflects broader economic uncertainties and the impact of regulatory decisions on market stability.

Deutsche Bank is exploring various strategies to manage its exposure to data centers amid the growing demand for AI lending. Executives are considering options such as shorting a basket of AI stocks or utilizing derivatives to effectively transfer risk.

Belite Bio recently presented at the Deutsche Bank Conference, showcasing their advancements in the treatment for Stargardt disease. Their innovative approach has garnered attention, highlighting the potential for improved outcomes for patients.

Deutsche Bank has stated that the recent reform of China's gold VAT is unlikely to significantly affect demand for gold. The bank's analysis suggests that while changes in tax policy can influence market dynamics, the overall impact on gold consumption in China will be minimal.

Deutsche Bank has reported a decrease in foreign exchange volatility as the initial shock from Trump's policies begins to fade. This positive trend suggests a more stable market environment, which could benefit investors and traders alike.

Deutsche Bank has downgraded Alvotech's stock to a 'Hold' rating due to ongoing manufacturing issues that could impact the company's performance. This decision is significant as it reflects concerns about Alvotech's ability to meet production standards, which may affect investor confidence and the stock's future trajectory.

Deutsche Bank has downgraded X-FAB's stock due to disappointing auto bookings, leading to a significant drop in shares. This is concerning for investors as it highlights potential challenges in the automotive sector, which could impact X-FAB's future performance and profitability. The downgrade reflects broader market sentiments and raises questions about the company's ability to recover in a competitive landscape.